A major decision looms over infant health in the US. A federal vaccine advisory panel is on the brink of voting on whether to alter the long-standing recommendation that all newborns receive the hepatitis B vaccine. This is a big deal because it could change how we protect our children from a serious liver disease.
The meeting, which was delayed and unusually heated, saw intense debate about limiting access to the hepatitis B vaccine for infants. The advisory committee on immunization practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on vaccine use, had already postponed the vote twice before.
Currently, the recommendation is to give the hepatitis B shot to all infants within 24 hours of birth. This is to prevent hepatitis B infection, which can cause severe liver damage. The vaccine has been administered to 1.4 billion people over more than 30 years.
But here's where it gets controversial... The meeting in Atlanta didn't present any new evidence of harm caused by the vaccine. However, the panel, appointed by Donald Trump's controversial health secretary, Robert F. Kennedy Jr., includes some vocal anti-vaccine advocates. Kennedy himself has been a long-time proponent of delaying the shot. Experts warn that any change to the current vaccination schedule could have serious consequences for children's health in the US.
During the meeting, Joseph Hibbeln, an ACIP member, asked a critical question: "Is there any specific evidence of harm of giving this vaccination before 30 days? Or is this speculation?" Mark Blaxill, an author who has argued that vaccines cause autism, responded that there is "limited evidence about the long-term risk." Hibbeln's response was telling: "So this was speculation and limited evidence. OK, got it."
The advisory panel can only make recommendations to the head of the CDC. The previous director was ousted by the Trump administration, who claimed she was "not aligned" with the president's agenda.
Earlier this year, Kennedy dismissed all 17 members of the advisory committee and replaced them with his own appointees, including several vaccine skeptics. This week, the panel's membership changed again. The most recent chair, Dr. Martin Kulldorff, left for an official role within the agency and was replaced by Dr. Kirk Milhoan, a cardiologist who has been critical of the Covid vaccine.
This is a complex issue with potentially significant implications. What are your thoughts on this? Do you think the current vaccination recommendations should be changed? Share your opinions in the comments below!
